Palynziq 2.5 mg (Pegvaliase SOLUTION) 2.5 MG

PALYNZIQ 2.5 MG is a subcutaneous solution containing pegvalgase, used for managing phenylketonuria (PKU). This medication helps break down phenylalanine, aiding in its management. Ideal for those seeking effective PKU treatment options.

Strength

2.5 MG

Manufacturer / TM Owner

BIOMARIN INTERNATIONAL LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PALYNZIQ 2.5 MG is primarily used for the long-term management of phenylketonuria (PKU). This condition is characterized by the body's inability to break down phenylalanine, an amino acid found in many foods. By administering this solution subcutaneously, it helps to reduce phenylalanine levels in the blood, supporting overall health and well-being. PALYNZIQ is often prescribed as part of a comprehensive treatment plan for PKU, which may include dietary restrictions and regular monitoring.

Side Effects

Common effects of PALYNZIQ 2.5 MG may include reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience headaches, nausea, or abdominal pain. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

PALYNZIQ 2.5 MG should be stored as directed to maintain its efficacy. It is important to follow the prescribed dosage and administration instructions carefully. Always inform your healthcare provider about any allergies or medical conditions before starting this treatment. Proper handling and disposal of the solution are crucial to ensure safety.

Avoid Interactions

PALYNZIQ 2.5 MG may interact with certain medications or substances. It is advisable to avoid alcohol while using this solution, as it can exacerbate side effects. Always consult with a healthcare provider before combining PALYNZIQ with other medications, especially those that affect the immune system or metabolism.

Frequently Asked Questions

PALYNZIQ 2.5 MG is used for the long-term management of phenylketonuria (PKU), helping to break down phenylalanine in the body.

PALYNZIQ 2.5 MG is administered subcutaneously, typically by injection, as directed by a healthcare provider.

Common side effects may include injection site reactions, headaches, nausea, and abdominal pain.

Consult a healthcare provider before combining PALYNZIQ 2.5 MG with other medications to avoid potential interactions.

PALYNZIQ 2.5 MG should be stored according to the instructions provided to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.